Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS

Journal of Proteome Research

Volumn 14, Issue 7, 2015, Pages 2872-2883

  Song, Ehwang ^a   Hu, Yunli ^a   Hussein, Ahmed ^a,c   Yu, Chuan Yih ^b   Tang, Haixu ^b   Mechref, Yehia ^a  

^a TEXAS TECH UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

D102N; glycopeptide; glycoproteomics; LC MS MS; missense mutation; N linked glycosylation; prostate specific antigen; PSA; rs61752561

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; ZINC;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; GLYCOSYLATION; LIQUID CHROMATOGRAPHY; MISSENSE MUTATION; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; CHEMISTRY; GENETICS; HUMAN; MOLECULAR GENETICS; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATE-SPECIFIC ANTIGEN; SEQUENCE HOMOLOGY, AMINO ACID; TANDEM MASS SPECTROMETRY;

EID: 84947260130     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00362     Document Type: Article

References (41)

1. Diamandis, E. P. Prostate-specific Antigen: Its Usefulness in Clinical Medicine Trends Endocrinol. Metab. 1998, 9 (8) 310-316
2. Watt, K. W.; Lee, P. J.; MTimkulu, T.; Chan, W. P.; Loor, R. Human prostate-specific antigen: structural and functional similarity with serine proteases Proc. Natl. Acad. Sci. U. S. A. 1986, 83 (10) 3166-3170
3. Borgoño, C. A.; Michael, I. P.; Diamandis, E. P. Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res. 2004, 2 (5) 257-280
4. Emami, N.; Diamandis, E. P. New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family Mol. Oncol. 2007, 1 (3) 269-287
5. Yousef, G. M.; Diamandis, E. P. The new human tissue kallikrein gene family: structure, function, and association to disease Endocr. Rev. 2001, 22 (2) 184-204
6. Grimwood, J.; Gordon, L. A.; Olsen, A.; Terry, A.; Schmutz, J.; Lamerdin, J.; Hellsten, U.; Goodstein, D.; Couronne, O.; Tran-Gyamfi, M.; Aerts, A.; Altherr, M.; Ashworth, L.; Bajorek, E.; Black, S.; Branscomb, E.; Caenepeel, S.; Carrano, A.; Caoile, C.; Chan, Y. M.; Christensen, M.; Cleland, C. A.; Copeland, A.; Dalin, E.; Dehal, P.; Denys, M.; Detter, J. C.; Escobar, J.; Flowers, D.; Fotopulos, D.; Garcia, C.; Georgescu, A. M.; Glavina, T.; Gomez, M.; Gonzales, E.; Groza, M.; Hammon, N.; Hawkins, T.; Haydu, L.; Ho, I.; Huang, W.; Israni, S.; Jett, J.; Kadner, K.; Kimball, H.; Kobayashi, A.; Larionov, V.; Leem, S. H.; Lopez, F.; Lou, Y.; Lowry, S.; Malfatti, S.; Martinez, D.; McCready, P.; Medina, C.; Morgan, J.; Nelson, K.; Nolan, M.; Ovcharenko, I.; Pitluck, S.; Pollard, M.; Popkie, A. P.; Predki, P.; Quan, G.; Ramirez, L.; Rash, S.; Retterer, J.; Rodriguez, A.; Rogers, S.; Salamov, A.; Salazar, A.; She, X.; Smith, D.; Slezak, T.; Solovyev, V.; Thayer, N.; Tice, H.; Tsai, M.; Ustaszewska, A.; Vo, N.; Wagner, M.; Wheeler, J.; Wu, K.; Xie, G.; Yang, J.; Dubchak, I.; Furey, T. S.; DeJong, P.; Dickson, M.; Gordon, D.; Eichler, E. E.; Pennacchio, L. A.; Richardson, P.; Stubbs, L.; Rokhsar, D. S.; Myers, R. M.; Rubin, E. M.; Lucas, S. M. The DNA sequence and biology of human chromosome 19 Nature 2004, 428 (6982) 529-535
7. Armbruster, D. A. Prostate-specific antigen: biochemistry, analytical methods, and clinical application Clin. Chem. 1993, 39 (2) 181-195
8. Mulders, T. M.; Bruning, P. F.; Bonfrer, J. M. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker Eur. J. Surg. Oncol. 1990, 16 (1) 37-41
9. Huber, P. R.; Schmid, H. P.; Mattarelli, G.; Strittmatter, B.; van Steenbrugge, G. J.; Maurer, A. Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate Prostate 1995, 27 (4) 212-219
10. Ohyama, C.; Hosono, M.; Nitta, K.; Oh-eda, M.; Yoshikawa, K.; Habuchi, T.; Arai, Y.; Fukuda, M. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy Glycobiology 2004, 14 (8) 671-679
11. Tabares, G.; Radcliffe, C. M.; Barrabes, S.; Ramirez, M.; Aleixandre, R. N.; Hoesel, W.; Dwek, R. A.; Rudd, P. M.; Peracaula, R.; de Llorens, R. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA Glycobiology 2006, 16 (2) 132-145
12. Zhang, W. M.; Leinonen, J.; Kalkkinen, N.; Dowell, B.; Stenman, U. H. Purification and characterization of different molecular forms of prostate-specific antigen in human seminal fluid Clin. Chem. 1995, 41 (11) 1567-1573
13. Charrier, J. P.; Tournel, C.; Michel, S.; Dalbon, P.; Jolivet, M. Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia Electrophoresis 1999, 20 (4-5) 1075-1081
14. Sarrats, A.; Saldova, R.; Comet, J.; ODonoghue, N.; de Llorens, R.; Rudd, P. M.; Peracaula, R. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma OMICS 2010, 14 (4) 465-474
15. Okada, T.; Sato, Y.; Kobayashi, N.; Sumida, K.; Satomura, S.; Matsuura, S.; Takasaki, M.; Endo, T. Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid Biochim. Biophys. Acta 2001, 1525 (1-2) 149-160
16. Peracaula, R.; Tabares, G.; Royle, L.; Harvey, D. J.; Dwek, R. A.; Rudd, P. M.; de Llorens, R. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins Glycobiology 2003, 13 (6) 457-470
17. Tajiri, M.; Ohyama, C.; Wada, Y. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: a glycopeptide approach Glycobiology 2008, 18 (1) 2-8
18. Song, E.; Mayampurath, A.; Yu, C. Y.; Tang, H.; Mechref, Y. Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS J. Proteome Res. 2014, 13 (12) 5570-5580
19. Leymarie, N.; Griffin, P. J.; Jonscher, K.; Kolarich, D.; Orlando, R.; McComb, M.; Zaia, J.; Aguilan, J.; Alley, W. R.; Altmann, F.; Ball, L. E.; Basumallick, L.; Bazemore-Walker, C. R.; Behnken, H.; Blank, M. A.; Brown, K. J.; Bunz, S. C.; Cairo, C. W.; Cipollo, J. F.; Daneshfar, R.; Desaire, H.; Drake, R. R.; Go, E. P.; Goldman, R.; Gruber, C.; Halim, A.; Hathout, Y.; Hensbergen, P. J.; Horn, D. M.; Hurum, D.; Jabs, W.; Larson, G.; Ly, M.; Mann, B. F.; Marx, K.; Mechref, Y.; Meyer, B.; Moginger, U.; Neususs, C.; Nilsson, J.; Novotny, M. V.; Nyalwidhe, J. O.; Packer, N. H.; Pompach, P.; Reiz, B.; Resemann, A.; Rohrer, J. S.; Ruthenbeck, A.; Sanda, M.; Schulz, J. M.; Schweiger-Hufnagel, U.; Sihlbom, C.; Song, E.; Staples, G. O.; Suckau, D.; Tang, H.; Thaysen-Andersen, M.; Viner, R. I.; An, Y.; Valmu, L.; Wada, Y.; Watson, M.; Windwarder, M.; Whittal, R.; Wuhrer, M.; Zhu, Y.; Zou, C. Interlaboratory Study on Differential Analysis of Protein Glycosylation by Mass Spectrometry: the ABRF Glycoprotein Research Multi-Institutional Study 2012 Mol. Cell. Proteomics 2013, 12 (10) 2935-2951
20. Behnken, H. N.; Ruthenbeck, A.; Schulz, J. M.; Meyer, B. Glycan analysis of Prostate Specific Antigen (PSA) directly from the intact glycoprotein by HR-ESI/TOF-MS J. Proteome Res. 2014, 13 (2) 997-1001
21. Couzin-Frankel, J. Genetic Analysis Points the Way to Individualized PSA Tests Science 2010, 330 (6011) 1602
22. Mononen, N.; Seppala, E. H.; Duggal, P.; Autio, V.; Ikonen, T.; Ellonen, P.; Saharinen, J.; Saarela, J.; Vihinen, M.; Tammela, T. L.; Kallioniemi, O.; Bailey-Wilson, J. E.; Schleutker, J. Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors Cancer Res. 2006, 66 (2) 743-747
23. Gallagher, D. J.; Vijai, J.; Cronin, A. M.; Bhatia, J.; Vickers, A. J.; Gaudet, M. M.; Fine, S.; Reuter, V.; Scher, H. I.; Hallden, C.; Dutra-Clarke, A.; Klein, R. J.; Scardino, P. T.; Eastham, J. A.; Lilja, H.; Kirchhoff, T.; Offit, K. Susceptibility loci associated with prostate cancer progression and mortality Clin. Cancer Res. 2010, 16 (10) 2819-2832
24. Parikh, H.; Deng, Z.; Yeager, M.; Boland, J.; Matthews, C.; Jia, J.; Collins, I.; White, A.; Burdett, L.; Hutchinson, A.; Qi, L.; Bacior, J.; Lonsberry, V.; Rodesch, M.; Jeddeloh, J.; Albert, T.; Halvensleben, H.; Harkins, T.; Ahn, J.; Berndt, S.; Chatterjee, N.; Hoover, R.; Thomas, G.; Hunter, D.; Hayes, R.; Chanock, S.; Amundadottir, L. A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33 Hum. Genet. 2010, 127 (1) 91-99
25. Klein, R. J.; Hallden, C.; Cronin, A. M.; Ploner, A.; Wiklund, F.; Bjartell, A. S.; Stattin, P.; Xu, J.; Scardino, P. T.; Offit, K.; Vickers, A. J.; Gronberg, H.; Lilja, H. Blood biomarker levels to aid discovery of cancer-related single-nucleotide polymorphisms: kallikreins and prostate cancer Cancer Prev. Res. 2010, 3 (5) 611-619
26. Penney, K. L.; Schumacher, F. R.; Kraft, P.; Mucci, L. A.; Sesso, H. D.; Ma, J.; Niu, Y.; Cheong, J. K.; Hunter, D. J.; Stampfer, M. J.; Hsu, S. I. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels Carcinogenesis 2011, 32 (6) 853-859
27. Rodriguez, S.; Al-Ghamdi, O. A.; Burrows, K.; Guthrie, P. A. I.; Lane, J. A.; Davis, M.; Marsden, G.; Alharbi, K. K.; Cox, A.; Hamdy, F. C.; Neal, D. E.; Donovan, J. L.; Day, I. N. M. Very Low PSA Concentrations and Deletions of the KLK3 Gene Clin. Chem. 2013, 59 (1) 234-244
28. Knipe, D. W.; Evans, D. M.; Kemp, J. P.; Eeles, R.; Easton, D. F.; Kote-Jarai, Z.; Al Olama, A. A.; Benlloch, S.; Donovan, J. L.; Hamdy, F. C.; Neal, D. E.; Davey Smith, G.; Lathrop, M.; Martin, R. M. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies Cancer Epidemiol., Biomarkers Prev. 2014, 23 (7) 1356-1365
29. Mechref, Y.; Kang, P.; Novotny, M. V. Solid-phase permethylation for glycomic analysis Methods Mol. Biol. 2009, 534, 53-64
30. Kang, P.; Mechref, Y.; Novotny, M. V. High-throughput solid-phase permethylation of glycans prior to mass spectrometry Rapid Commun. Mass Spectrom. 2008, 22 (5) 721-734
31. Kang, P.; Mechref, Y.; Klouckova, I.; Novotny, M. V. Solid-phase permethylation of glycans for mass spectrometric analysis Rapid Commun. Mass Spectrom. 2005, 19 (23) 3421-3428
32. Desantos-Garcia, J. L.; Khalil, S. I.; Hussein, A.; Hu, Y.; Mechref, Y. Enhanced sensitivity of LC-MS analysis of permethylated N-glycans through online purification Electrophoresis 2011, 32 (24) 3516-3525
33. Brosch, M.; Yu, L.; Hubbard, T.; Choudhary, J. Accurate and sensitive peptide identification with Mascot Percolator J. Proteome Res. 2009, 8 (6) 3176-3181
34. Kruger, R.; Hung, C. W.; Edelson-Averbukh, M.; Lehmann, W. D. Iodoacetamide-alkylated methionine can mimic neutral loss of phosphoric acid from phosphopeptides as exemplified by nano-electrospray ionization quadrupole time-of-flight parent ion scanning Rapid Commun. Mass Spectrom. 2005, 19 (12) 1709-1716
35. Lundwall, Å.; Lilja, H. Molecular cloning of human prostate specific antigen cDNA FEBS Lett. 1987, 214 (2) 317-322
36. Heuze-Vourch, N.; Leblond, V.; Courty, Y. Complex alternative splicing of the hKLK3 gene coding for the tumor marker PSA (prostate-specific-antigen) Eur. J. Biochem. 2003, 270 (4) 706-714
37. Ménez, R.; Michel, S.; Muller, B. H.; Bossus, M.; Ducancel, F.; Jolivet-Reynaud, C.; Stura, E. A. Crystal Structure of a Ternary Complex between Human Prostate-specific Antigen, Its Substrate Acyl Intermediate and an Activating Antibody J. Mol. Biol. 2008, 376 (4) 1021-1033
38. Villoutreix, B. O.; Getzoff, E. D.; Griffin, J. H. A structural model for the prostate disease marker, human prostate-specific antigen Protein Sci. 1994, 3 (11) 2033-2044
39. Coombs, G. S.; Bergstrom, R. C.; Pellequer, J.-L.; Baker, S. I.; Navre, M.; Smith, M. M.; Tainer, J. A.; Madison, E. L.; Corey, D. R. Substrate specificity of prostate-specific antigen (PSA) Chem. Biol. 1998, 5 (9) 475-488
40. Guo, S.; Skala, W.; Magdolen, V.; Brandstetter, H.; Goettig, P. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity Biol. Chem. 2014, 395 (9) 959-976
41. Dam, S.; Thaysen-Andersen, M.; Stenkjær, E.; Lorentzen, A.; Roepstorff, P.; Packer, N. H.; Stougaard, J. Combined N-Glycome and N-Glycoproteome Analysis of the Lotus japonicus Seed Globulin Fraction Shows Conservation of Protein Structure and Glycosylation in Legumes J. Proteome Res. 2013, 12 (7) 3383-3392